Skip to main content
. 2017 Nov 1;8(61):104664–104686. doi: 10.18632/oncotarget.22272

Table 3. Conventional chemotherapy in patients with T-PLL.

N ORR (%) CR (%) Median OS (months)
alkylating agents (1) 32 31 3 7.5a
Pentostatin (90)b 55 45 9 17.5/9c
Pentostatin (91)d 25 8 0 4
Bendamustine (102)b 15 53.3 20 8.7

a median OS of the entire group of 78 patients treated by various therapies, b relapsed/refractory and treatment-naïve patients, c median OS: 17.5 months for responders and 9 months for non-responders, d relapsed/refractory patients.